In an effort to effectively address global health concerns, the WHO has announced the 13th General Programme of Work, a 5-year strategic plan spanning from 2019 to 2023.
Skin disorders, particularly those with known inflammatory mechanisms, may be considered potential early markers for the development of insulin resistance leading to metabolic syndrome, type 2 diabetes, and cardiovascular disease.
Obesity has a substantial effect on general health parameters, but its role in rheumatoid arthritis is much more complex.
The 2017 revisions to the Common Rule deal largely with improving the transparency and clarity of intended uses under the current standard of informed consent while introducing a new concept of “broad consent” that can significantly expand the reach of research that continues to yield new and important information.
Increasing waist circumference in midlife increases the risk of cognitive decline in late life.
Hyperglycemia treatment was left to physician’s discretion.
Accountable Care Organizations have potential to improve the quality of and access to care, with continued evaluation and adaptation.
The prevalence of diabetes and impairment in glucose metabolism are noticeably higher in psychiatric patients.
Current overall costs for medical liability in the United States range from $55.6 to $200 billion annually, which accounts for 2.4% to 10% of all healthcare spending.
Despite improved coverage, many Medicaid beneficiaries experienced increased wait times.
